Jennifer Johannesen

Cadena Research empowers radiopharmaceutical innovators by delivering tailored solutions that accelerate the path to clinical translation. Hamilton, Ontario – September 29, 2025 – CPDC, a global leader in the development and commercialization of radiopharmaceuticals, is proud to announce the launch of Cadena Research, a new preclinical contract research organization (CRO) offering specialized support for early-stage … Read more

Today, at the Canadian Radiotheranostics Leaders’ Summit (Toronto, ON) the Centre for Probe Development and Commercialization (CPDC) announced that it will be launching a Contract Research Organization (CRO) later this summer, with the aim to address the need to accelerate drug development in the radiopharmaceutical space. CPDC has a history of advancing nuclear medicine and … Read more